IP Library Granted Patent US 10,159,653
Granted Patent B2
US 10,159,653 · App. 15/103,458 · Granted Dec 25, 2018

Methods and compositions for increasing energy expenditure using cinnamaldehyde

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,159,653
App. No.
15/103,458
Granted
Dec 25, 2018
Kind
B2
Abstract

Compositions comprise an amount of cinnamaldehyde that is orally tolerable, thus avoiding an unpleasant mouth feeling, and also tolerable in the gastrointestinal tract. The amount of cinnamaldehyde is effective to increase at least one of energy expenditure, sympathetic nervous system activity, or fat oxidation, relative to a composition lacking cinnamaldehyde but otherwise identical. The composition comprising cinnamaldehyde can be used in a method to support weight management or promote weight loss, a method for preventing obesity or overweight, and a method for treating obesity or overweight. In an embodiment, the composition comprising cinnamaldehyde is administered to a human. The composition comprising cinnamaldehyde may be a medicament, a food product or a supplement to a food product.

Claims (13)

1. A method of increasing at least one characteristic selected from the group consisting of energy expenditure, sympathetic nervous system activity, and fat oxidation, the method comprising orally administering to a mammal maintaining a body mass index (BMI) of 18.5-25 a composition that is a food product comprising cinnamaldehyde, and a concentration of the cinnamaldehyde in the composition is 17.48 ppm to 6191.0 ppm relative to the composition.

2. The method of claim 1 wherein the cinnamaldehyde is administered to the mammal in an amount of about 1.25 mg/kg body weight per day.

3. The method of claim 1 wherein the cinnamaldehyde is present in the composition in a concentration of about 350 ppm.

4. The method of claim 1 wherein the composition comprising cinnamaldehyde is administered to the mammal once daily.

5. The method of claim 1 wherein the composition comprises cinnamon essential oil extract that provides at least a portion of the cinnamaldehyde.

6. The method of claim 1 wherein at least a portion of the cinnamaldehyde is selected from the group consisting of isolated cinnamaldehyde and synthesized cinnamaldehyde.

7. The method of claim 1 wherein the food product comprises a component selected from the group consisting of protein, carbohydrate, fat and combinations thereof.

8. The method of claim 1 wherein the composition further comprises an additional ingredient in a therapeutically effective amount to promote weight maintenance or weight loss.

9. An orally administered composition that is a food product comprising cinnamaldehyde, wherein a concentration of the cinnamaldehyde in the composition is 17.48 ppm to 6191.0 ppm relative to the composition, the composition is effective to maintain a body mass index (BMI) of 18.5-25 and to increase at least one characteristic selected from the group consisting of energy expenditure, sympathetic nervous system activity, and fat oxidation.

10. The composition of claim 9 wherein the composition is a food product in which the cinnamaldehyde is present in a concentration of about 350 ppm.

11. The composition of claim 9 wherein the composition is a food product comprising a component selected from the group consisting of protein, carbohydrate, fat and combinations thereof.

12. The composition of claim 9 wherein the composition is selected from the group consisting of a medicament, a food product, and a supplement to a food product.

13. The composition of claim 9 wherein the composition further comprises an additional ingredient in a therapeutically effective amount to promote weight maintenance or weight loss.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0001 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0165 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ENGLISH TRANSLATION TO SHOW THE FULL AND CORRECT NEW NAME IN SECTION 51. PREVIOUSLY RECORDED AT REEL: 049391 FRAME: 0756. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Jun 13, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049853/0398 →
MERGER Recorded Jun 6, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049391/0756 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2017
From: MICHLIG GONZALEZ, STEPHANIE; LE COUTRE, JOHANNES
To: NESTEC S.A.
Reel/Frame 043179/0187 →